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Abstract
Background: Members of racial and ethnic minority groups are most likely to experience limited access and poor
engagement in addiction treatment. Research has been limited on the role of program capacity and delivery of
comprehensive care in improving access and retention among minorities with drug abuse issues. The goal of this
study was to examine the extent to which access and retention are enhanced when racial and ethnic minorities
receive care from high-capacity addiction health services (AHS) programs and via coordination with mental health
and receipt of HIV testing services.
Methods: This multilevel cross-sectional analysis involved data from 108 programs merged with client data from 2011 for
13,478 adults entering AHS. Multilevel negative binomial regression models were used to test interactions and indirect
relationships between program capacity and days to enter treatment (wait time) and days in treatment (retention).
Results: Compared to low-capacity programs and non-Latino and non-African American clients, Latinos and African
Americans served in high-capacity programs reported shorter wait times to admission, as hypothesized. African Americans
also had longer treatment retention in high-capacity programs. Receipt of HIV testing and program coordination of
mental health services played an indirect role in the relationship between program capacity and wait time.
Conclusions: Program capacity and coordinated services in AHS may reduce disparities in access to care. Implications
for supporting low-capacity programs to eliminate the disparity gap in access to care are discussed.
Keywords: Program capacity, Comprehensive care, Racial and ethnic minorities, Wait time, Retention
Background
Addiction health services (AHS) programs face significant
challenges to develop capacity to expand service delivery
and enhance engagement of clients in treatment [1]. The
Affordable Care Act provides an opportunity to expand
AHS capacity by increasing access to public health insur-
ance and encouraging service integration [2]. This is par-
ticularly critical for underserved populations that face
numerous barriers to accessing AHS, resulting in dispar-
ities in access to needed services [3]. Therefore, it is crit-
ical to understand program factors that may facilitate the
delivery of coordinated care services in AHS to reduce
disparities in access and engagement among low-income
and racial and ethnic minority populations [3–5]. Building
on a recent study suggesting that high program capacity
helps reduce client wait time and increase retention in
AHS programs [6], the current study examined the extent
to which access and retention are enhanced when racial
and ethnic minorities receive care from high-capacity
AHS programs and via coordination with mental health
providers and receipt of HIV testing services.
Among individuals seeking help for substance abuse
issues, waiting to enter treatment is the most commonly
cited barrier [7–9], and treatment access and retention
are critical predictors of reduced posttreatment sub-
stance use [10, 11]. Exploring program factors, such as
program capacity, that enhance client wait time and re-
tention in AHS is critical because these outcomes are
important predictors of treatment success and increas-
ingly used in program evaluation [5, 6, 12, 13]. Although
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program capacity is frequently assessed using measures
of organizational size (such as number of clients served
or number of staff members), we developed a more
comprehensive measure of program capacity that re-
flects the necessary components (i.e., funding, workforce
and infrastructure, and leadership) to thrive in the
current health care service context. We defined high-
capacity AHS programs as those with high directorial
leadership capacity, organizational readiness for change
(ORC), and capacity to bill Medicaid [6].
Leadership is essential to fostering change, developing
resources, and improving performance [14], particularly
directorial leadership that is transactional (relies on in-
centives) and transformational (promotes human devel-
opment) [15]. Leadership influences the implementation
of evidence-based practices and provision of integrated
services [16, 17], and leadership behavior is associated
with client wait time [18]. ORC, a widely used construct
of AHS program functioning, is associated with effective
implementation of new practices and innovations [19].
In addition, clients in programs with high levels of ORC
report greater treatment rapport, satisfaction, and par-
ticipation [20]. Finally, in this era of Medicaid expansion,
acceptance of Medicaid provides revenue that allows
programs to support more services, comply with quality
expectations from funders, and enhance access for low-
income individuals [1–3, 6]. In previous work, we dem-
onstrated how a latent class variable using leadership,
ORC, and Medicaid acceptance can serve as a proxy for
program capacity and distinguish between high- and
low-capacity programs based on client outcomes. In this
study, we used this latent program capacity variable to
efficiently examine the extent to which disparities in wait
time and retention are reduced when racial and ethnic
minorities receive treatment from high-capacity pro-
grams and via coordination with mental health and re-
ceipt of HIV testing services.
Racial and ethnic minorities such as African
Americans and Latinos often fare worse than their
White counterparts in terms of wait time and retention
[3, 21]. Emerging research has suggested that treatment
disparities exist partly because racial and ethnic minority
clients are more likely to access low-capacity programs
that are not able to meet their service needs [6, 22].
However, high-capacity programs have the resources to
facilitate greater knowledge of and connections with
their communities and are more responsive to the needs
of the minority populations they serve. Therefore, they
may be able to tailor outreach and engagement to Latino
and African American clients, enhancing wait time and
retention for these clients beyond that of Whites. Hence,
we tested whether receiving care from a high-capacity
program that has strong leadership, readiness to adopt
new practices, and acceptance of public insurance
eliminates differences among racial and ethnic groups in
key measures of treatment engagement. We posited in Hy-
pothesis 1 that African American and Latino clients acces-
sing high-capacity AHS programs would have (a) lower
wait time and (b) increased retention compared to Whites.
Coordination of care can help reduce disparities and
improve treatment outcomes [22]. AHS coordination
with services such as mental health treatment and health
counseling is associated with improved client retention
in treatment and posttreatment substance use [23]. The
Affordable Care Act and Mental Health Parity and Ad-
diction Equity Act provide incentives for coordination of
care by requiring health insurance plans to offer mental
health and substance abuse treatment at the same level
as medical benefits [1, 24]. As more individuals enter
treatment, organizations will likely seek partnerships to
accommodate the demand. Because mental health and
HIV testing services are two of the most needed services
for clients in publicly funded AHS programs [5, 22, 25]
and previous work has shown that components of high-
capacity programs are associated with coordination of
mental health and HIV testing services [26], we exam-
ined the extent to which coordinated care is the mech-
anism by which program capacity is associated with wait
time and retention. We posited in Hypothesis 2 that
high-capacity programs would be indirectly associated
with (a) reduced client wait time and (b) increased client
retention through coordination of mental health and re-
ceipt of HIV testing services.
Methods
Sampling frame
This study used a fully concatenated program and cli-
ent dataset collected in 2010 and 2011. The sampling
procedures for these data have been described in de-
tail elsewhere [6]. All study procedures were approved
by the University of Southern California Institutional
Review Board. The analytic sample for the current
study consisted of 108 AHS programs and 13,478 cli-
ent treatment episodes drawn from programs located
in communities with a population of 40 % or more
African American or Latino residents or both in Los
Angeles County. Program-level data were collected
from a clinical supervisor at each agency via elec-
tronic surveys, with informed consent obtained prior
to beginning the survey. Site visits to review program
records or collect additional data used to cross-
validate program-level survey data were conducted
with 91 % of programs. Client data were collected as
part of the Los Angeles County Participant Reporting
System, the countywide administrative data system re-
quired of publicly funded programs, and electronically
recorded by clinicians at admission and discharge.
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Measures
Dependent variables were wait time and retention. Wait
time was measured as the number of days each client re-
ported spending on a waiting list prior to starting treat-
ment. Retention was measured as the number of days
between admission and discharge dates as reported by
program staff members in the Los Angeles County Par-
ticipant Reporting System. These measures are widely
used in addiction services research and have been previ-
ously demonstrated to be predictive of positive treat-
ment outcomes [5, 11, 27]. Table 1 features the response
format and Cronbach’s alpha values of study measures,
including a list of independent and control variables.
Our independent variables were program capacity and
coordination of services. Measure development is de-
scribed in detail elsewhere [13]. Program capacity was
measured by a latent class variable using the following
three variables: (a) leadership, (b) ORC, and (c) accept-
ance of Medi-Cal payments (California’s Medicaid pro-
gram). We measured leadership using the Multifactor
Leadership Questionnaire [15]. Clinical supervisors rated
their director’s leadership on a 5-point scale (1 = strongly
disagree to 5 = strongly agree), and scores were totaled as
recommended. We used the Organizational Readiness
for Change Scale to measure program readiness to im-
plement new practices. ORC was measured with 67
items divided into four domains with 18 subscales: mo-
tivational readiness (three subscales: program and train-
ing needs, and pressure for change); resources (five
subscales: offices, staffing, training resources, equipment,
and Internet access); staff attributes (four subscales:
growth, efficacy, influence, and adaptability); and
organizational climate (six subscales; mission, cohesion,
autonomy, communication, and change) [19, 28]. Items
were rated on a 5-point Likert scale (1 = strongly disagree
to 5 = strongly agree). Items from subscales were added
and averaged to create scores for each of the four do-
mains, which in turn were averaged and multiplied by
10 to develop the ORC total mean score; higher scores
indicated greater readiness. Item examples and alpha
levels are provided for all subscales in Table 1. We also
measured acceptance of Medi-Cal with a single item
asking whether providers had the capacity to accept
Medi-Cal payments.
To develop the latent class variable, we relied on latent
profile analysis to identify levels of program capacity. La-
tent profile analysis can incorporate continuous, ordinal,
and categorical indicators, in contrast to latent class ana-
lysis, which can only accommodate categorical indica-
tors. We determined latent classes that represented
different levels of program capacity by considering dif-
ferent solutions for multiple latent profiles (e.g., two
classes, three classes, etc.). The full procedure is de-
scribed in a previous study [6]. The fundamental












In Equation 1, i and j (i ≠ j) are index-specific variables
and k designates a specific latent class, such that μik rep-
resents the mean and σ2ijk represents the variance for
variable i in group j, k is the total number of latent clas-
ses, and πk indicates the proportion of cases belonging
to each class (
PK
k¼1πk ¼ 1). We selected two as the ap-
propriate number of latent classes after testing several
models. These two classes represented high- and low-
capacity programs, categories represented in the field as
small recovery programs and large health care providers
[1, 5]. To create two interactions using program capacity
and race and ethnicity, we first developed mutually ex-
clusive categories of race (non-Latino White and non-
Latino African American), and ethnicity (non-White and
non-African American Latino). The interactions in-
cluded a dichotomous measure of program capacity
(high vs. low) and race (African American vs. non-
African American) and program capacity (high vs. low)
and ethnicity (Latino vs. non-Latino).
To assess coordination with mental health providers,
supervisors rated how frequently their program collabo-
rated with mental health and psychiatric providers to co-
ordinate care for clients with dual disorders (1 = never to
5 = always). This measure resulted in bimodal distribu-
tions in the never, almost never, and always categories;
thus, we transformed it to a dichotomous measure
representing high coordination with mental health pro-
viders. To measure receipt of HIV testing services dur-
ing treatment, clients reported at discharge whether they
received HIV testing on- or off-site while in treatment.
Variables had less than 8 % missing data, with the ex-
ception of the motivational readiness subscale of the
ORC scale (13.97 %) and public funding (8.56 %). We
handled missing data using multiple imputation, in
which each missing value was replaced with 20 plausible
values using the Markov Chain Monte Carlo method
[30]. We imputed program and client variables separ-
ately using fully conditional specification for multivariate
imputation [31]. We developed, merged, and analyzed
the 20 imputed datasets using Stata’s MI IMPUTE and
MI ESTIMATE commands.
Statistical analysis
We used multilevel negative binomial regression with
robust standard errors in Stata for our analyses, using
MI ESTIMATE: NBREG with a log link function [32, 33).
The CLUSTER option was used to account for the
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Table 1 Program (N = 108) and client (N = 13,478) variables in addiction health services
Mean ± Standard
Deviation or n (%)
Response format
Dependent variables
Wait time 3.36 ± 16.63 Time to enter treatment (days)
Retention 90.46 ± 99.72 Treatment duration (days)
Independent variables
Program capacity
High program capacity 8 (7.4) Latent class (high leadership, readiness for change, Medi-Cal acceptance)
Directorial leadership 40.11 ± 7.04 9 items, scale from 10 (low) to 50 (high); e.g., Your director inspires others with plans
for the facility’s future; α = .96
Readiness for change 34.53 ± 2.80 4 subscales, scale from 10 (low) to 50 (high).
Motivational readinessa: 24 items, 30.78 ± 5.68, e.g., Your program needs more training
for effective implementation of EBPs; α = .80
Resources: 12 items, 37.94 ± 5.15, e.g., Clinical management decisions for your
program are well planned; α = .74
Staff attributes: 8 items, 40.30 ± 4.01, e.g. You are able to adapt quickly when you have
to make changes; α = .86
Organizational climate: 16 items, 34.66 ± 4.90, e.g. You feel encouraged to try new and
different techniques; α = .78
Medi-Cal acceptance 81 (75) Program accepts Medi-Cal payment
Mental health coordination 45 (42) On-site and off-site coordination with mental health services
Receipt of HIV testing servicesb 8,165 (74) Number of clients who received on-site and off-site HIV testing services while in the
program
Client race and ethnicity
African American 2,731 (20) Self-identify as African American
Latino 5,010 (37) Self-identify as Latino
White 4,179 (31) Self-identify as White (non-Latino)
Other 1,558 (12) Self-identify as other race or ethnicity
Control variables
Program characteristics
Public fundinga 34.2 ± 43.0 Percentage of public funding during previous fiscal year
License 103 (96.3) Licensed by state
Accreditation 16 (15.2) Accredited by the Joint Commission
Program type
Outpatient 60 (55.6) Primarily outpatient services
Methadone 4 (3.7) Primarily methadone maintenance services
Residential 36 (33.3) Primary residential services
Client characteristics
Referral sourceb
Self 5,780 (43) Self-referred
Community 2,262 (17) Referred by a community organization
Proposition 36 1,896 (14) Referred by court in lieu of incarceration
Drug court 755 (6) Referred by drug court
Social services 2,785 (21) Referred by social services or county agency
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multilevel structure of the data (clients nested in pro-
grams) and obtain more accurate estimates of standard er-
rors [34]. The negative binomial approach was used
because the dependent variables were overdispersed count
measures of number of days (i.e., their variance was much
greater than their mean). Hence, results are expressed as
incidence rate ratios (IRR), interpreted as the estimated
rate ratio for a 1-unit increase in the independent variable,
given the other variables are held constant in the model.
To test our hypotheses regarding whether the relationship
between program capacity and client wait time (Hypoth-
esis 1a) and retention (Hypothesis 1b) differed by client
race and ethnicity, we conducted multilevel linear model-
ing [32]. To test our hypotheses regarding the indirect re-
lationship between program capacity and client wait time
(Hypothesis 2a) and retention (Hypothesis 2b) via coord-
ination with mental health and receipt of HIV prevention
services, we used path analysis in R package mediation
with a bootstrap p-value specification [35].
Results
Descriptive statistics for all variables are shown Table 1.
Hypothesis testing results are shown in Table 2 and Fig. 1
and account for all control variables. There were only
eight programs (7 %) with high capacity in leadership,
high ORC, and acceptance of Medi-Cal payments; 42 %
of programs had high coordination with mental health
providers and 48 % facilitated HIV testing services on-
or off-site to 74 % of clients who received this service
during treatment. The average client wait time was
3 days, whereas the average duration in treatment was
90 days. Latinos represented 37 % of the client popula-
tion, whereas African Americans represented 20 %.
We found support for Hypothesis 1a, which posited that
the relationship between high-capacity AHS programs and
client wait time would be moderated by client minority sta-
tus. Latino (IRR = 0.131; 95 % CI = 0.065, 0.267; p < .001)
and African American (IRR = 0.237; 95 % CI = 0.170, 0.332;
p < .001) clients entering high-capacity programs had sig-
nificantly shorter wait times compared to Whites.
We found partial support for Hypothesis 1b, which
stated that the relationship between high-capacity pro-
grams and client retention in treatment would be mod-
erated by client minority status. African American
clients (IRR = 1.315; 95 % CI = 1.170, 1.479; p < .001) had
significantly greater retention in treatment than White
clients. However, Latino clients were not associated with
greater retention in treatment at a statistically significant
level (p > .05).
We found support for Hypothesis 2a, which posited
that program capacity would be indirectly associated
with client wait time through coordination of care.
Program capacity was indirectly associated with client
wait time through both coordination with mental health
services (standardized indirect effect = −.259, bootstrap
p < .01) and receipt of HIV testing services (standardized
indirect effect = −.016, bootstrap p < .01). We did not
find support for Hypothesis 2b regarding the relation-
ship among coordination of care, receipt of HIV testing
services, and client retention.
Two components of program capacity (Medi-Cal ac-
ceptance and ORC) were negatively associated with wait
time, whereas only ORC was associated with higher reten-
tion (IRR = 1.014; 95 % CI = 1.001, 1.026; p = .04). Receipt
of HIV testing services was positively associated with wait
time (IRR = 1.300; 95 % CI = 1.197, 1.413; p < .001).
Among control variables, public funding (IRR = 0.995;
95 % CI = 0.993, 0.997; p < .001), methadone (IRR = 0.381;
95 % CI = 0.180, 0.804; p < .05), and community referrals
(IRR = 0.839; 95 % CI = 0.712, 0.988; p < .05) were
negatively associated with wait time, whereas drug court
referral (IRR = 1.209; 95 % CI = 1.133, 1.290; p < .001),
Medi-Cal eligibility (IRR = 1.132; 95 % CI = 1.084,
1.182; p < .001), and homelessness (IRR = 1.065; 95 %
CI = 1.021, 1.112; p < .01) were positively associated
with retention.
Discussion
This paper examined the extent to which access and re-
tention are enhanced when racial and ethnic minorities
receive care from high-capacity AHS programs and via
coordination with mental health providers and receipt of
HIV testing services. Findings demonstrate how program
capacity, as measured in this study, can be used to fur-
ther examine pathways and interacting relationships that
may improve access to care (i.e., wait time). Race and
ethnicity and coordinated mental health and receipt of
HIV testing services played an important role in redu-
cing wait time. Path analysis showed that high-capacity
programs are associated with lower wait time for all cli-
ents through coordination with mental health providers
and receipt of HIV testing services. Albeit conjectural, it
Table 1 Program (N = 108) and client (N = 13,478) variables in addiction health services (Continued)
Medi-Cal eligible 5,350 (40) Eligible for Medi-Cal
Mental health issues 3,205 (24) Diagnosed with mental health issue
Homeless 2,296 (17) Unstable housing status
aMore than 8 % data missing
bClient-reported characteristic
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may be that high-capacity programs situated in commu-
nities with large percentages of racial and ethnic minor-
ity groups are better able to address specific barriers to
treatment and provide more rapid treatment entry by
connecting with mental health and HIV testing pro-
viders. Programs that understand their community’s ser-
vice needs may become more responsive to clients’
treatment access needs.
Findings also showed that when African American
clients entered high-capacity programs, they experienced
longer treatment retention than Whites and clients en-
tering low-capacity programs. These results suggest that
high-capacity programs are better able to engage African
Americans, potentially providing care that aligns better
with their needs. Engaging clients in treatment is cer-
tainly a complex issue. Although we accounted for client
and program factors that play a role in retention, other
factors were not included in this study, such as a client’s
psychological readiness to engage in treatment and re-
ceipt of needed services [23].
However, our latent concept of program capacity
allowed us to test a conceptual framework of capacity and
follow an efficient methodological approach to compare
programs using a multilevel path analysis with complex
outcomes (number of days to enter and stay in treatment).
This approach is needed to compare programs in a large
system of care, such as the AHS system in Los Angeles
County, with the purpose of informing system-level inter-
ventions. However, understanding the role of different
components of program capacity (leadership, ORC, and
Medi-Cal payment acceptance) in wait time and retention
is also critical, particularly to inform program-level inter-
ventions. Results provided in Table 2 show that two cap-
acity factors (ORC and Medi-Cal payment acceptance)
were associated with lower wait time, whereas only ORC
was associated with higher retention in treatment. These
findings support the notion that access to care for low-
income populations may be driven by public funding and
regulatory and program practices and resources, and that
these practices and clients’ referral from criminal justice
and eligibility for Medi-Cal also play an important role in
retention.
Another important contribution of this paper is its
preliminary evidence suggesting that coordination with
mental health providers and receipt of HIV testing ser-
vices enable high-capacity programs to reduce client
wait times. High-capacity programs seem to have more
resources in terms of infrastructure, workforce training,
leadership, and funding. Through their network connec-
tions with other providers offering needed services, these
high-capacity programs may be able to get clients into
treatment faster. However, coordination of specific ser-
vices, such as mental health treatment or HIV testing,
did not play a role in the relationship between program
capacity and retention. To address the possibility that
our measure of retention did not accurately reflect suc-
cessful engagement, we conducted post hoc analyses
with completion of the treatment episode as the out-
come. These results also showed a statistically nonsignif-
icant path through coordination of services in the
Fig. 1 Program capacity, service coordination, and wait time and retention among minorities. Note: Only significant indirect paths are reported.
P-values represent bootstrap p-values. Dotted lines represent estimates including mental health coordination indirect path; solid lines represent
path estimates including receipt of HIV testing services indirect path. White is the reference category for race and ethnicity; low program capacity
is the reference category for high program capacity. The analytic sample is N = 13,478. We adjusted for program-level variables (private insurance,
organizational cultural competence, and public funding) and client-level variables (gender, mental illness, homelessness, Medi-Cal eligibility, referral type,
race, treatment type)
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relationship between program capacity and treatment
completion. One explanation for these findings may be
that our measurements of mental health coordination at
the program level did not allow us to assess whether cli-
ents most in need of mental health services actually re-
ceived these services, thus supporting successful
completion of their treatment episode. Ensuring receipt
of needed services seems critical in engagement; previ-
ous research has demonstrated improved retention
based on matching services with client needs [23]. In
addition, it is likely that client characteristics, such as
drug use severity and socioeconomic status, play a more
salient role in treatment retention than program factors
such as coordination of services [22].
Limitations associated with study data must be consid-
ered when interpreting findings. First, although our ana-
lysis examined direct and indirect relationships, we did
not extend our results to causal or temporal relationships
given that our data were cross-sectional. Our path analysis
approach was informed by our conceptual framework
Table 2 Multi-level negative binomial models of wait time and retention (N = 13,478)
Wait time Retention
IRR 95 % CI IRR 95 % CI
Program capacity
Latent variable components
Medi-Cal acceptance 0.564*** 0.489, 0.650 1.041 0.975, 1.112
Readiness for change 0.705*** 0.679, 0.732 1.014* 1.001, 1.026
Directorial leadership 1.004 0.991, 1.016 1.000 0.994, 1.006
Program capacity × Latinoa 0.131*** 0.065, 0.267 1.118 0.950, 1.317
Program capacity × African Americana 0.237*** 0.170, 0.332 1.315*** 1.170, 1.479
Organizational characteristics
Cultural competence 1.021 0.997, 1.047 1.007 0.997, 1.017
Mental health coordination 1.116 0.919, 1.354 0.970 0.904, 1.040
Public funding 0.995*** 0.993, 0.997 1.000 0.999, 1.001
Program typeb
Methadone 0.381* 0.180, 0.804 0.834** 0.738, 0.942
Residential 4.011*** 3.517, 4.576 0.588*** 0.561, 0.616
Client characteristics
Receipt of HIV testing services 1.300*** 1.197, 1.413 0.973 0.943, 1.005
Referral sourcec
Community 0.839* 0.712, 0.988 1.024 0.975, 1.074
Proposition 36 1.560*** 1.376, 1.770 0.897*** 0.848, 0.948
Drug court 0.992 0.835, 1.177 1.209*** 1.133, 1.290
Social service 1.042 0.952, 1.140 0.921*** 0.882, 0.962
Medi-Cal eligible 0.990 0.893, 1.098 1.132*** 1.084, 1.182
Race and ethnicityd
African American 7.610*** 3.636, 15.928 0.952 0.797, 1.136
Latino 4.558*** 3.195, 6.503 0.787*** 0.692, 0.896
Other 0.766** 0.632, 0.928 1.067 0.997, 1.141
History of mental health 0.907* 0.828, 0.994 0.976 0.941, 1.012
Homeless 1.194*** 1.097, 1.300 1.065** 1.021, 1.112
CI confidence interval; IRR incidence rate ratio. IRRs can be interpreted as the estimated rate ratio for a 1-unit increase in the independent variable, given the other
variables are held constant in the model. For example, compared to programs that do not accept Medi-Cal, programs accepting Medi-Cal are associated with a
decreased ratio of number of days waiting of IRR = 0.564, while holding all other variables in the model constant. Model statistics for wait time: F(21, 9199.7) = 80.20, p-value
of F < 1 = .0001. Model statistics for retention: F(21, 40245.1) = 49.9, p-value of F < 1 = .0001. The corresponding p-value is less than .001
aLow program capacity and non-Latino White are reference categories
bOutpatient is reference category
cSelf-referral is reference category
dNon-Latino White is reference category
*p < .05, **p < .01, ***p < .001
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described in the introduction. Second, program mea-
sures were provided by one manager per program
and may have been influenced by social desirability
bias. We attempted to reduce this bias by completing
validity checks with 91 % of the sample during site
visits. This procedure is described elsewhere [36].
Nonetheless, our results are robust because of our
use of large multilevel data on clients and programs
and reliance on a representative sample of programs
serving urban communities in Los Angeles County
with more than 7 million residents.
Conclusions
Results highlight the importance of measuring pro-
gram capacity in the rapidly changing service delivery
environment in the current health care reform con-
text. Findings may inform system and program inter-
ventions. Programs can be distinguished based on
their capacity—for example, low-capacity programs
can be quickly targeted with system interventions to
improve client outcomes throughout the county. As a
program-level intervention, it is critical to invest in
leadership training, staff readiness for change, and
Medi-Cal payment acceptance and reporting capacity
to improve the quality of care provided to under-
served clients. Although current federal programs
sponsored by the Substance Abuse and Mental Health
Services Administration on leadership development
[37], evidence-based practice training, Medicaid pay-
ment acceptance, and integration of care [38, 39] are
available, these programs may not be sufficient to
reach low-capacity community-based treatment pro-
grams. These programs need significant direct support
from their local government and service networks to
build capacity in the components reported here to
have the potential to eliminate the current disparity
gap in access to care.
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